Get in touch

Reflections from AI in Pharma event in Basel

Reflections from AI in Pharma event in Basel

Our Head of Global Digitalization & AI, Sayan Sarkar, recently joined the AI in Pharma Project Management event by Why Summits? in Basel on stage and as panelist, sharing insights on how Artificial Intelligence is reshaping the way pharma companies work. While AI continues to dominate today’s discussions, Sayan highlighted that the real needs of […]

Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa

Tiefenbacher Group - A smiling older man with a gray beard sits while a woman stands behind him, hugging him. Text reads, "LAUNCH OF BUPRENORPHINE IN SOUTH AFRICA." The TIEFENBACHER PHARMACEUTICALS logo is at the top, highlighting expertise in generic medicines manufacturing.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa. We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That’s why we are thrilled to share that we have successfully prepared the launch of the generic version […]

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher Group - A smiling woman in a navy raincoat stands on a beach, holding her hood. The AET TIEFENBACHER PHARMACEUTICALS logo appears in the top left, reflecting their focus on patient-centric drug development. The background shows the sea and greenery.

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]

State-of-the-art R&D facilities for powerful drug development

Tiefenbacher Group - A large group gathers outdoors under a colorful canopy for a groundbreaking ceremony as a priest leads rituals. Highlighting Tiefenbacher Group’s family-owned pharmaceutical company and patient-centric drug development, event details frame the image.

State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticalsWe, at Tiefenbacher Group, go beyond R&D and manufacturing of pharmaceuticals with a commitment to quality, safety, and reliability that is anchored in everything we do. We continuously expand in novel technologies and capabilities to improve quality and […]

Get in touch